Endogenous PROM1 activation redistributes liver cancer cells along a preexisting differentiation axis
CD133 is widely used as a marker of stem-like cells in hepatocellular carcinoma, yet its functional contribution remains incompletely defined. In PLC/PRF/5 cells, acute CRISPR activation of endogenous PROM1 suppresses hepatic programs, whereas PROM1 knockdown elicits an opposing hepatocyte-identity response, together defining a PROM1-responsive transcriptional axis. Single-cell profiling shows…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
